| Lisinopril, Hydrochlorothiazide |
II-5295/30.06.2009 |
Co-Linipril, Tablet, 20 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
10.31 |
2.06 |
12.37 |
6% |
0.62 |
10.93 |
2.19 |
13.12 |
18% |
1.86 |
12.79 |
2.56 |
15.35 |
КЦ-1775/20.09.2010 ; КЦPP-1006/23.07.2012 промяна на обстоятелства |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
2129 |
| Colistimethate sodium |
20170268 |
Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Дания |
59.22 |
11.84 |
71.06 |
4% |
2.37 |
61.59 |
12.32 |
73.91 |
16% |
9.48 |
71.07 |
14.21 |
85.28 |
Протокол №345/22.08.2019 |
НСР-19168/04.07.2019 |
19.07.2019 |
02.08.2019 |
Активен |
16608 |
| Colistimethate sodium |
20170268 |
Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Дания |
59.22 |
11.84 |
71.06 |
4% |
2.37 |
61.59 |
12.32 |
73.91 |
16% |
9.48 |
71.07 |
14.21 |
85.28 |
|
НСР-19168/04.07.2019 |
19.07.2019 |
02.08.2019 |
Неактивен |
16608 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018;Протокол №345/22.08.2019 |
02.11.2018 |
02.11.2018 |
Активен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018 |
02.11.2018 |
02.11.2018 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.53 |
35.31 |
211.84 |
4% |
7.06 |
183.59 |
36.72 |
220.31 |
16% |
25 |
208.59 |
41.72 |
250.31 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018 |
02.08.2018 |
02.08.2018 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017 |
02.09.2017 |
02.09.2017 |
Неактивен |
3060 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
106.71 |
21.34 |
128.05 |
4% |
4.27 |
110.98 |
22.2 |
133.18 |
16% |
17.07 |
128.05 |
25.61 |
153.66 |
|
НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017; НСР-14654/18.12.2017 и НСР-14734/22.12.2017 (предварително изпълнение) |
02.12.2017 |
02.01.2018 |
Заличен |
2243 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
106.71 |
21.34 |
128.05 |
4% |
4.27 |
110.98 |
22.2 |
133.18 |
16% |
17.07 |
128.05 |
25.61 |
153.66 |
|
НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017 |
02.12.2017 |
02.12.2017 |
Неактивен |
2243 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
449.84 |
89.97 |
539.81 |
4% |
10 |
459.84 |
91.97 |
551.81 |
16% |
25 |
484.84 |
96.97 |
581.81 |
|
НСР-1875/27.11.2013 |
28.11.2013 |
28.11.2013 |
Неактивен |
2243 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.53 |
35.31 |
211.84 |
4% |
7.06 |
183.59 |
36.72 |
220.31 |
16% |
25 |
208.59 |
41.72 |
250.31 |
|
НСР-4253/30.07.2014 |
13.08.2014 |
13.08.2014 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.65 |
35.33 |
211.98 |
4% |
7.07 |
183.72 |
36.74 |
220.46 |
16% |
25 |
208.72 |
41.74 |
250.46 |
|
НСР-1875/27.11.2013 |
28.11.2013 |
28.11.2013 |
Неактивен |
3060 |
| Colistimethate sodium |
20170247 |
COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 |
Tarchomin Pharmaceutical Works "Polfa" S.A., Полша |
Tarchomin Pharmaceutical Works “Polfa” S.A., Полша |
118.46 |
23.69 |
142.15 |
4% |
4.74 |
123.2 |
24.64 |
147.84 |
16% |
18.95 |
142.15 |
28.43 |
170.58 |
Протокол №345/22.08.2019 |
НСР-17343/30.11.2018 |
15.12.2018 |
02.01.2019 |
Активен |
16363 |
| Colistimethate sodium |
20170247 |
COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 |
Tarchomin Pharmaceutical Works "Polfa" S.A., Полша |
Tarchomin Pharmaceutical Works “Polfa” S.A., Полша |
118.46 |
23.69 |
142.15 |
4% |
4.74 |
123.2 |
24.64 |
147.84 |
16% |
18.95 |
142.15 |
28.43 |
170.58 |
|
НСР-17343/30.11.2018 |
15.12.2018 |
02.01.2019 |
Неактивен |
16363 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), IU, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018;Протокол №345/22.08.2019 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.01.2019 |
Активен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.01.2019 |
Неактивен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.07.2017 |
Неактивен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Forest Laboratories UK Ltd., Обединено Кралство |
Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
|
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
13.11.2015 |
Неактивен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Forest Laboratories UK Ltd., Обединено Кралство |
Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
|
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
13.11.2015 |
Неактивен |
4102 |
| Capecitabine |
20130065 |
Coloxet, Film coated tablet, 150, mg, Pack: 60 |
EGIS Pharmaceuticals PLC, Унгария |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Ltd, Малта |
32.45 |
6.49 |
38.94 |
4% |
1.3 |
33.75 |
6.75 |
40.5 |
16% |
5.19 |
38.94 |
7.79 |
46.73 |
цената се заличава с решение НСР-6729/16.07.2015 (в сила от 16.08.2015 ) |
НСР-5517/29.01.2015 |
12.02.2015 |
12.02.2015 |
Заличен |
3532 |
| Capecitabine |
20130065 |
Coloxet, Film coated tablet, 150, mg, Pack: 60 |
EGIS Pharmaceuticals PLC, Унгария |
Accord Healthcare Limited, Обедине-но кралство; Pharmacare Premium Ltd, Малта |
37.14 |
7.43 |
44.57 |
4% |
1.49 |
38.63 |
7.73 |
46.36 |
16% |
5.94 |
44.57 |
8.91 |
53.48 |
|
НСР-1288/03.10.2013 |
17.12.2013 |
17.12.2013 |
Неактивен |
3532 |
| Capecitabine |
20130067 |
Coloxet, Film coated tablet, 500, mg, Pack: 120 |
EGIS Pharmaceuticals PLC, Унгария |
Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Ltd, Малта |
216.31 |
43.26 |
259.57 |
4% |
8.65 |
224.96 |
44.99 |
269.95 |
16% |
25 |
249.96 |
49.99 |
299.95 |
цената се заличава с решение НСР-6730/16.07.2015 (в сила от 16.08.2015 ) |
НСР-5518/29.01.2015 |
12.02.2015 |
12.02.2015 |
Заличен |
3533 |
| Capecitabine |
20130067 |
Coloxet, Film coated tablet, 500, mg, Pack: 120 |
EGIS Pharmaceuticals PLC, Унгария |
Accord Healthcare Limited, Обедине-но кралство; Pharmacare Premium Ltd, Малта |
246.34 |
49.27 |
295.61 |
4% |
9.85 |
256.19 |
51.24 |
307.43 |
16% |
25 |
281.19 |
56.24 |
337.43 |
|
НСР-1288/03.10.2013 |
17.12.2013 |
17.12.2013 |
Неактивен |
3533 |
| Zidovudine and lamivudine |
EU/1/98/058/001 |
COMBIVIR, Film coated tablet, 150 mg/300 mg, mg, Pack: 60 |
Viiv Healthcare BV, Нидерландия |
Glaxo Operations UK Ltd, Великобритания; GlaxoSmithKline Pharmaceuticals S.A. Полша |
96.46 |
19.29 |
115.75 |
4% |
3.86 |
100.32 |
20.06 |
120.38 |
16% |
15.43 |
115.75 |
23.15 |
138.9 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-322/17.06.2015; Промяна на обстоятелства НСР-18232/22.03.2019 |
НСР-5806/12.03.2015; КП-125/25.11.2016 и НСР-10438/29.09.2016 |
02.01.2017 |
02.05.2019 |
Активен |
3007 |
| Zidovudine and lamivudine |
EU/1/98/058/001 |
COMBIVIR, Film coated tablet, 150 mg/300 mg, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Operations UK Ltd, Великобритания; GlaxoSmithKline Pharmaceuticals S.A. Полша |
96.46 |
19.29 |
115.75 |
4% |
3.86 |
100.32 |
20.06 |
120.38 |
16% |
15.43 |
115.75 |
23.15 |
138.9 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-322/17.06.2015 |
НСР-5806/12.03.2015; КП-125/25.11.2016 и НСР-10438/29.09.2016 |
02.01.2017 |
02.01.2017 |
Неактивен |
3007 |